Literature DB >> 1658103

Measurement of brain phosphoinositide metabolism in bipolar patients using in vivo 31P-MRS.

T Kato1, T Shioiri, S Takahashi, T Inubushi.   

Abstract

In vivo phosphorus-31 magnetic resonance spectroscopy (31P-MRS) was used to measure phosphorus metabolism in the brains of manic patients treated with lithium carbonate. The phosphomonoester (PME) peak was elevated in the manic state in patients with DSM-IIIR bipolar disorder compared to the euthymic state and to drug-free normal controls. Elevation of the PME peak may be caused by lithium-induced accumulation of inositol 1-phosphate in the brain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1658103     DOI: 10.1016/0165-0327(91)90064-y

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  8 in total

1.  Decreased brain PME/PDE ratio in bipolar disorder: a preliminary (31) P magnetic resonance spectroscopy study.

Authors:  Xian-Feng Shi; Paul J Carlson; Young-Hoon Sung; Kristen K Fiedler; Lauren N Forrest; Tracy L Hellem; Rebekah S Huber; Seong-Eun Kim; Chun Zuo; Eun-Kee Jeong; Perry F Renshaw; Douglas G Kondo
Journal:  Bipolar Disord       Date:  2015-10-19       Impact factor: 6.744

Review 2.  Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications.

Authors:  Tadafumi Kato
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

Review 3.  Purinergic system dysfunction in mood disorders: a key target for developing improved therapeutics.

Authors:  Robin Ortiz; Henning Ulrich; Carlos A Zarate; Rodrigo Machado-Vieira
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2014-11-07       Impact factor: 5.067

4.  Choline-containing compounds detected by proton magnetic resonance spectroscopy in the basal ganglia in bipolar disorder.

Authors:  T Kato; H Hamakawa; T Shioiri; J Murashita; Y Takahashi; S Takahashi; T Inubushi
Journal:  J Psychiatry Neurosci       Date:  1996-07       Impact factor: 6.186

5.  Serum phosphatidylinositol as a biomarker for bipolar disorder liability.

Authors:  Emma Em Knowles; Peter J Meikle; Kevin Huynh; Harald Hh Göring; Rene L Olvera; Samuel R Mathias; Ravi Duggirala; Laura Almasy; John Blangero; Joanne E Curran; David C Glahn
Journal:  Bipolar Disord       Date:  2017-02-23       Impact factor: 6.744

6.  Neurochemical abnormalities in unmedicated bipolar depression and mania: a 2D 1H MRS investigation.

Authors:  Jun Xu; Ulrike Dydak; Jaroslaw Harezlak; Jonathan Nixon; Mario Dzemidzic; Abigail D Gunn; Harish S Karne; Amit Anand
Journal:  Psychiatry Res       Date:  2013-06-27       Impact factor: 3.222

Review 7.  Inositol depletion, GSK3 inhibition and bipolar disorder.

Authors:  Wenxi Yu; Miriam L Greenberg
Journal:  Future Neurol       Date:  2016-04-26

Review 8.  Lithium as a Neuroprotective Agent for Bipolar Disorder: An Overview.

Authors:  Enrique L M Ochoa
Journal:  Cell Mol Neurobiol       Date:  2021-08-06       Impact factor: 5.046

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.